Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001195-13Phase 4Completed
Phase 4, randomised, open-label trial in opioid use disorder (OUD) comparing Buprenorphine (Subutex) detoxification with Methadone detoxification (2 arms). Primary endpoint: Abstinence at completion of 21-day detoxification regimen. Started Jul 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001195-13.